Kate Khorsand, MD
Dermatology · Coeur D Alene, IDNPI 1780095638
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 225 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 21.5% — the pattern of someone who eats at a lot of different presentations.
Across 225 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$836
- Johnson & Johnson$794
- Lilly USA, LLC$597
- UCB, Inc.$411
- Regeneron Healthcare Solutions, Inc.$378
- Novartis$340
- plus $528 from 13 others
What the payments were for
- Food & beverage$3,78697%
- Education$993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $836 |
| Johnson & Johnson | 52 | $794 |
| Lilly USA, LLC | 35 | $597 |
| UCB, Inc. | 28 | $411 |
| Regeneron Healthcare Solutions, Inc. | 13 | $378 |
| Novartis | 18 | $340 |
| Sanofi | 8 | $172 |
| Amgen | 4 | $99 |
| E.r. Squibb & Sons, L.L.C. | 4 | $67 |
| Arcutis Biotherapeutics, Inc. | 2 | $34 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| Biofrontera Inc. | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $19 |
| Genentech USA, Inc. | 1 | $17 |
| Incyte Corporation | 1 | $17 |
| Janssen Scientific Affairs, LLC | 1 | $16 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Pfizer | 1 | $12 |
How this compares
$3,885 in reported general payments places this provider in the 70th percentile of 52 dermatology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 36 | $133,831 |
| Clobetasol Propionate | 94 | $4,479 |
| Fluorouracil | 39 | $2,918 |
| Triamcinolone Acetonide | 92 | $1,324 |
| Fluocinonide | 15 | $1,193 |
| Dapsone | 17 | $1,193 |
| Desonide | 14 | $947 |
| Metronidazole | 12 | $803 |
| Ketoconazole | 47 | $736 |
| Doxycycline Hyclate | 40 | $595 |
| ValacyclovirValacyclovir Hcl | 19 | $535 |
| Mupirocin | 22 | $189 |
| Nystatin | 14 | $163 |
| Cephalexin | 18 | $61 |
| Prednisone | 18 | $56 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Coeur D Alene
- Hilary HillCoeur D Alene$3K
- Benjamin RinggerCoeur D Alene$3K
- Dustin LarsenCoeur D Alene$2K
- Alicia OgramCoeur D Alene$236
- Alan OlmsteadTwin Falls$405K
- Dustin PortelaBoise$164K
- Steven MingsBoise$82K
- Ryan HarrisMeridian$58K
- Jeffrey DraluckNorthbrook$36K
- Mark SchwendimanMeridian$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.